By jurisdiction
Australia (TGA)
Every compound we track that has a recorded status under Australia (TGA). Tap a name for the full picture, including the U.S. status and primary sources.
| Compound | Status here | Note |
|---|---|---|
| AOD-9604 | Restricted | Named in Schedule 4 (prescription only) of the Poisons Standard and in Appendix D item 5 (possession without authority is illegal), entries made by a 2015 scheduling decision. |
| BPC-157 | Restricted | Reported as Schedule 4 (prescription-only) under the Poisons Standard. |
| CJC-1295 | Restricted | Reported as Schedule 4 (prescription-only) under the Poisons Standard. |
| Ipamorelin | Restricted | Reported as Schedule 4 (prescription-only) under the Poisons Standard. |
| Melanotan II | Restricted | Schedule 4 (prescription-only); no products registered on the ARTG; TGA has issued infringement notices for unlawful supply. |
| NAD+ | Restricted | Per an April 2025 TGA safety alert, NAD/NAD+/NADH are not permitted ingredients in listed medicines. |
| Retatrutide | Restricted | Not in the ARTG; the TGA names retatrutide among unapproved peptide products and takes enforcement action against unlawful import, compounding, supply and advertising. Victoria’s Chief Health Officer issued a health alert on Jun 19, 2026 (still active) after six cases of acute liver injury since January 2026 in people who used products labelled Retatrutide, Reta, R-10 or R-20. |
| Semaglutide (compounded) | Restricted | GLP-1 analogues removed from the pharmacist compounding exemption effective Oct 1, 2024; remains Schedule 4. |
| Sermorelin | Restricted | Schedule 4 (prescription-only), named individually in the Poisons Standard (October 2026), and possession without authority is illegal (Appendix D). No product on the ARTG. |
| TB-500 (Thymosin Beta-4) | Restricted | Thymosin beta-4 treated as Schedule 4 (prescription-only) under the Poisons Standard. |
| Tesamorelin | Restricted | Not named individually in the Poisons Standard (October 2026), but Appendix D lists growth hormone releasing hormones (GHRHs) as a group among poisons that are illegal to possess without authority. No product on the ARTG. |
| Thymosin Alpha-1 | Restricted | Regulated as Schedule 4 (prescription-only); the TGA has enforced against unlawful advertising. |
| Tirzepatide (compounded) | Restricted | GLP-1 compounding prohibited since Oct 1, 2024; remains Schedule 4. |
| Cagrilintide | Unscheduled | Not individually named or scheduled in the Poisons Standard. |
| Dihexa | Unscheduled | Not individually named in the Poisons Standard (October 2026) and no product on the ARTG; supply for human use is unlawful without ARTG registration, and the TGA is enforcing against unapproved peptides. |
| Emideltide (DSIP) | Unscheduled | Not individually named in the Poisons Standard; supply for human use is unlawful without ARTG registration, and the TGA is enforcing against unapproved peptides. |
| Epitalon | Unscheduled | Not individually named in the Poisons Standard; supply for human use is unlawful without ARTG registration, and the TGA is enforcing against unapproved peptides. |
| GHK-Cu | Unscheduled | Not individually named in the Poisons Standard; topical cosmetic products are freely available. |
| Kisspeptin-10 | Unscheduled | Not individually named in the Poisons Standard (October 2026) and no product on the ARTG; supply for human use is unlawful without ARTG registration, and the TGA is enforcing against unapproved peptides. |
| KPV | Unscheduled | Not individually named in the Poisons Standard; supply for human use is unlawful without ARTG registration, and the TGA is enforcing against unapproved peptides. |
| LL-37 (cathelicidin) | Unscheduled | Not individually named in the Poisons Standard (October 2026) and no product on the ARTG; supply for human use is unlawful without ARTG registration, and the TGA is enforcing against unapproved peptides. |
| MOTS-c | Unscheduled | Not individually named in the Poisons Standard; supply for human use is unlawful without ARTG registration, and the TGA is enforcing against unapproved peptides. |
| PT-141 (bremelanotide) | Unscheduled | Not individually named in the Poisons Standard (October 2026) and no product on the ARTG; supply for human use is unlawful without ARTG registration, and the TGA is enforcing against unapproved peptides. |
| Selank | Unscheduled | Not individually named or scheduled in the Poisons Standard. |
| Semax | Unscheduled | Not individually named in the Poisons Standard; sits in a grey area. |
| SS-31 (elamipretide) | Unscheduled | Not individually named in the Poisons Standard (October 2026) and no product on the ARTG; supply for human use is unlawful without ARTG registration, and the TGA is enforcing against unapproved peptides. |